Hydromer Inc. announced that during August it had entered into two royalty bearing license agreements, one with a US-based medical device company, and one with a China-based medical device company. Under the terms of these agreements, each company is licensed to use certain proprietary Hydromer(R) medical coatings on medical devices, such as vascular access guidewires, nasogastic feeding catheters and gastrointestinal placement stylets.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.35 USD | -35.19% | -.--% | +89.19% |
01-16 | Hydromer, Inc. Announces Sales Results for the Fiscal Year Ended December 31, 2023 | CI |
01-16 | Hydromer, Inc. Revises Fiscal Year from June 30 to December 31 | CI |
1st Jan change | Capi. | |
---|---|---|
+89.19% | 1.93M | |
+17.07% | 66.31B | |
-0.29% | 48.46B | |
+21.61% | 43.27B | |
+26.72% | 27.41B | |
+9.25% | 19.26B | |
-2.14% | 16.61B | |
+9.75% | 16.58B | |
-15.01% | 14.41B | |
-30.22% | 14.02B |
- Stock Market
- Equities
- HYDI Stock
- News Hydromer, Inc.
- Hydromer, Inc. Enters into Two Royalty Bearing Medical Coating Licenses in August 2012